RoverMed BioScience

RoverMed BioScience, founded in 2017 and headquartered in Minnesota, USA, is a biotechnology company. The company is committed to pioneering nanotechnology therapies to treat diseases that are difficult to cure with traditional methods. Currently, RoverMed has successfully developed precision-targeted drugs for solid tumors in the head and neck, prostate, and human gastrointestinal tract. RoverMed's nanocapsule technology has been recognized and supported by GeneSegues Therapeutics, an American biotechnology company. This technology can carry macromolecules, naked DNA, and viral particles through biological barriers into the nuclei of target cells located anywhere in the human body, without affecting healthy cells. This nanotechnology enhances the delivery efficiency and precise targeting of therapeutic agents, allowing the drug to enter the cell interior upon repeated administration to achieve the desired treatment effect.